Generate a tailored SOP for Dr. Helen Stölting. Improve your application with a focused, well-structured draft.
Dr. Helen Stölting completed her undergraduate studies in Molecular Biomedicine at the University of Bonn, Germany, engaging in a research project on the evolution of IL-1 in invertebrate and vertebrate species. Following internships in industry and academia, Dr. Stölting moved to Imperial College London, UK, where she earned a Master’s degree in Immunology, working under Professor Clare Lloyd at the National Heart and Lung Institute on a project focused on IL-10-driven macrophage and T-cell interactions that shape pulmonary immune responses in severe asthma. She completed her PhD at Imperial College London from 2018 to 2023, continuing her research within Prof. Lloyd’s group, concentrating on EGFR signaling in pulmonary immune responses to allergens and viruses, especially focusing on early life. Dr. Stölting investigates how primary airway epithelial cells from pediatric and adult subjects react to respiratory viruses, including SARS-CoV-2 and Influenza. In late 2023, she became a Postdoctoral Research Fellow at Monash University in the Nutrient Metabolism Signaling laboratory, focusing on metabolism, diabetes, and obesity as part of the Biomedicine Discovery Institute. Her research explores the intersection of metabolism and invasive fungal infections, using complex mouse models to study Candida albicans and its relationship to metabolic diseases like obesity and diabetes.
Monash University • Melbourne
Conducting research in the Nutrient Metabolism Signaling laboratory, focusing on the interplay of metabolism and invasive fungal infections.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.